<DOC>
	<DOC>NCT02541006</DOC>
	<brief_summary>The objective of this study is to compare the bronchodilator efficacy a of tiotropium inhalation via DISCAIR (18 mcg once daily) and SPIRIVA HANDIHALER® (18 mcg once daily) in patients with moderate to severe chronic obstructive pulmonary disease (COPD).</brief_summary>
	<brief_title>Comparison 24 Hour Bronchodilator Efficacy of Tiotropium 18 mcg Delivered Via DISCAIR Versus SPIRIVA 18 µg Delivered Via HANDIHALER® in Patients With Moderate to Severe COPD</brief_title>
	<detailed_description />
	<mesh_term>Bronchodilator Agents</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Patients aged 40 years and older with moderate to severe COPD diagnosis Current/former smokers with at least a 10 packyear history of cigarette smoking Patients with established clinical COPD and severity defined as a postbroncodilator FEV1/FVC ratio of ≤0.70 and FEV1 ≤80 % of predicted normal at screening Females of nonchild bearing potential or females of child bearing potential with negative pregnancy test; and acceptable contraceptive methods Have no excacerbation within last 4 weeks Hava capability of communicate with investigator Accept to adapt the procedures of study protocol Signed and dated informed consent History of hypersensitivity to anticholinergics Diagnosis of asthma History of alergic rinit and athopy Current or history of lung cancer Known symptomatic prostatic hypertrophy requiring drug therapy Known narrowangle glaucoma requiring drug therapy Have experienced exacerbation of COPD or lower respiratory inflammatory disease requiring use of antibiotics, oral or parenteral corticosteroids (CS) within 4 weeks prior to screening visit and/or during runin period Patients vaccinated with poored virüs vaccinate within 2 weeks prior to screening visit and/or during runin period Patients with a recent history of myocardial infarction, acute ischemic cardiac disease or severe cardiac arrhythmia requiring drug therapy Women who are pregnant or lactating or are planning on becoming pregnant during the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>FEV1</keyword>
	<keyword>FVC</keyword>
	<keyword>AUC 0-24</keyword>
	<keyword>bronchodilator efficacy</keyword>
	<keyword>tiotropium</keyword>
</DOC>